Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
MJH has received speaker fees from MSD, BMS, AstraZeneca, Roche, Lilly, and Boehringer Ingelheim.
Open access publication of this article was funded by Boehringer Ingelheim. This work was supported by Boehringer Ingelhelim. Medical writing assistance, supported finanically by Boehringer Ingelheim, was provided by Helen Kitchen and Hashem Dbouk of GeoMed, an Ashfield company, part of the UDG Healthcare plc, during the preparation of this article. Boehringer Ingelheim was involved in the preparation of the manuscript.
This video is distributed under the terms of the Creative Commons Attribution Noncommerical Licence which permits any noncommerical use, distribution, and reproduction in any medium, provided the original author(s) and the source is credited.
The full text of this article can be found here.